SOX7 and hepatocellular carcinoma: According to their report, miR-452 maintains the stemness of HCC by targeting SOX7 and directly binding to the β-catenin/TCF/LEF transcriptional factor complex to relieve the suppression of SOX7 to the Wnt/β-catenin signaling pathway [128].